Hypoxia-induced activation of HIF as well as pharmacologic inhibition of HIF-hydroxylases induces transcription of genes including erythropoietin (EPO) and its receptor transferrin in vivo and in vitro, thereby ameliorating anemia [36,37]. The gene discussed is EPO; the disease is anemia (phenotype).